Patric Stenberg

Gesynta Pharma (Sweden) — Sweden

Chemistry · Physical Sciences

12h-index2.1kcitations14works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Analytical Chemistry and Chromatography(6), Drug Transport and Resistance Mechanisms(5), Inflammatory mediators and NSAID effects(5), Computational Drug Discovery Methods(4), Drug Solubulity and Delivery Systems(4)

Publications14 total

Biological characterization of new inhibitors of microsomal PGE synthase‐1 in preclinical models of inflammation and vascular tone
British Journal of Pharmacology·2019· 31 citedOpen Access
Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation
Prostaglandins & Other Lipid Mediators·2013· 70 cited
Characterization of a new mPGES-1 inhibitor in rat models of inflammation
Prostaglandins & Other Lipid Mediators·2013· 31 cited
A Facilitated Approach to Evaluate the Inhibitor Mode and Potency of Compounds Targeting Microsomal Prostaglandin E Synthase-1
Assay and Drug Development Technologies·2011· 10 cited
Identification of Key Residues Determining Species Differences in Inhibitor Binding of Microsomal Prostaglandin E Synthase-1*
Journal of Biological Chemistry·2010· 75 citedOpen Access
Theoretical Predictions of Drug Absorption in Drug Discovery and Development
Clinical Pharmacokinetics·2002· 82 cited
Transport of Lipophilic Drug Molecules in a New Mucus-Secreting Cell Culture Model Based on HT29-MTX Cells
Pharmaceutical Research·2001· 218 cited
Experimental and Computational Screening Models for the Prediction of Intestinal Drug Absorption
Journal of Medicinal Chemistry·2001· 250 cited
Computational models for the prediction of intestinal membrane permeability.
KTH Publication Database DiVA (KTH Royal Institute of Technology)·2001· 5 citedOpen Access
Virtual screening of intestinal drug permeability
Journal of Controlled Release·2000· 107 cited
Prediction of the Intestinal Absorption of Endothelin Receptor Antagonists Using Three Theoretical Methods of Increasing Complexity
Pharmaceutical Research·1999· 65 cited
Chitosans as absorption enhancers of poorly absorbable drugs
European Journal of Pharmaceutical Sciences·1999· 278 cited
Prediction of Membrane Permeability to Peptides from Calculated Dynamic Molecular Surface Properties
Pharmaceutical Research·1999· 83 cited
Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans
Pharmaceutical Research·1997· 746 cited

Frequent Co-authors

Per Artursson(8), Kristina Luthman(6), Linda Spahiu(5), Per‐Johan Jakobsson(4), Sven‐Christian Pawelzik(3), Ralf Morgenstern(3), Charlotte Larsson(3), Johan Wannberg(3), Marina Korotkova(3), Patrick Leclerc(2), Helena Idborg(2), Natalia Nekhotiaeva(2), Katrin Palm(1), Nicolaas Schipper(1), Kjell M. Vårum(1), Göran Ocklind(1), Hans Lennernäs(1), Ulf Norinder(1), Isabel Behrens(1), Thomas Kissel(1)